BioCareSD, a specialty distributor of life-saving therapies, today announced the addition of VIBATIV® and ULTOMIRIS® to its already extensive portfolio of life-saving therapies.
Leading Specialty Distributor Continues to Expand Product Offerings to Service Additional Patients
TEMPE, Ariz. – December 6, 2022 – BioCareSD, a specialty distributor of life-saving therapies, today announced the addition of VIBATIV® and ULTOMIRIS® to its already extensive portfolio of life-saving therapies. With an ongoing commitment to broadening its product portfolio, BioCareSD is dedicated to meeting customer demand and providing essential products to patients in need.
VIBATIV is a lipoglycopeptide antibacterial indicated for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria.
ULTOMIRIS is a complement inhibitor used to treat:
- Adult and pediatric patients one month of age and older with paroxysmal nocturnal hemoglobinuria (PNH).
- Adult and pediatric patients one month of age and older with atypical hemolytic uremic syndrome (aHUS) to inhibit complement mediated thrombotic microangiopathy (TMA).
- Adult patients with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody-positive.
With more than four decades of specialty distribution experience, BioCareSD exists to provide fast and easy access to life-saving medications. Trusted by manufacturers and healthcare providers alike, BioCareSD provides customizable solutions to ensure exceptional customer service and the highest quality patient care.
“We are constantly expanding our product portfolio so that our customers and their patients have dependable and timely access to much-needed – and in some instances, life-saving – therapies,” said Andrew Kirk, chief revenue officer at BioCareSD. “Serving as a true partner, we will always prioritize identifying and supporting our customers’ needs to the best of our abilities.”
This news comes shortly after BioCareSD announced a contract with UCB, leading to the addition of six new products to its portfolio: BRIVIACT®, CIMZIA®, NAYZILAM®, NEUPRO®, KEPPRA® and VIMPAT®.
For more information, please visit www.biocaresd.com.
About BioCareSD
BioCareSD is a leading national specialty distributor of life-saving therapies. Headquartered in Phoenix, Arizona, BioCareSD has been devoted to delivering specialty and therapeutic biological products since 1982. BioCareSD is part of BioCare, Inc., which also encompasses CanyonCareRX, a full-service specialty pharmacy, LogiCare3PL, a national provider of time and temperature-sensitive pharmaceutical logistics services, and QRCare, a quality and regulatory consultancy service. BioCare, Inc. was included on the Inc. 5000 Fastest-Growing Private Companies in America list in 2022. For more information about BioCareSD, please visit www.biocaresd.com.
###
Media Contact:
Macy Hyland, Crowe PR
mhyland@crowepr.com | 541.556.4054